Stryker Corporation (SYK) Financials, Dividends & Stock Info
Explore comprehensive financial data for Stryker Corporation, provided completely free. Analyze revenue, net income, profit margins, dividend history, and key financial ratios to make informed investment decisions.
Data as of (572 days ago)|Source: SEC EDGAR
The information on this page is for informational purposes only and does not constitute investment advice, financial advice, or any recommendation. Billiver does not recommend buying, selling, or holding any security. Past performance is not indicative of future results.
Data may be delayed and accuracy is not guaranteed. All investment decisions are solely your responsibility. Verify information independently and consult a qualified financial advisor before investing. About · Methodology
Stryker Corporation (SYK) is a health care equipment company. The company reports annual revenue of $22.6B and net income of $3.0B. Its profit margin is 13.3%.
Stryker Corporation Key Financials(TTM Est.)
Data from SEC EDGAR filings. TTM = Trailing Twelve Months.
Stryker Corporation Financial Health ScoreFY2025
Moderate health; several metrics need attention
-15 pts YoYThis Financial Health Score is a proprietary metric calculated from SEC EDGAR filings for educational and informational purposes only. It does not constitute investment advice or a recommendation to buy or sell any security. Results vary significantly by industry. Conduct your own research before making investment decisions.
Data Highlights
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Stryker Corporation Recent Events
Source: SEC EDGAR 8-K Filings
5-Year Revenue & Net Income Trend
Chart shows fiscal year data from SEC EDGAR filings. Hover over data points for details.
As of FY2025 · SEC 10-K · Updated Jun 30, 2026
Revenue Breakdown (FY2024)
See Stryker Corporation detailed breakdown →Showing top 3 of 12 segments
About Stryker Corporation
Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. The company's products are used for medical surgery and neurotechnology, which include surgical equipment, patient and caregiver safety technologies, endoscopy systems, and patient handling, emergency medical equipment, and intensive care disposable products, as well as neurosurgical, neurovascular and oral and maxillofacial surgery implant products; and orthopedic surgery, which includes implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. Stryker's products are sold in over 75 countries and are used by 150 million patients annually. In 2024, 75% of the company's revenues came from the United States.
- Industry
- Health Care Equipment
Valuation
Valuation Data UnavailablePrice-based valuation metrics (P/E, P/B) require real-time stock price data which is not included in SEC filings.
Benjamin Graham: Graham recommended P/E ratio not exceed 15 for reasonable valuation. Understanding valuation metrics
Profitability
Positive Marginsvs 7.9% sector median / 7.6% avg
Keeps 13 cents of every dollar in revenue as profit. Higher than 67% in Health Care.
* Some quarterly data is missing. Values are calculated based on annual report figures.
Profit margin 75% above sector average.
Warren Buffett: Buffett looks for consistent ROE above 20% as a sign of competitive advantage. How to evaluate profitability
Financial Health
Balance Sheet Data LimitedInsufficient data to assess financial health.
Peter Lynch: Lynch: normal balance sheet has 75% equity, 25% debt. Understanding financial health
Dividend
Dividend Data UnavailableDividend yield data is not available from SEC filings. Check the company's investor relations page for dividend information.
As of FY2025 · SEC 10-K · Updated Jun 30, 2026
Stryker Corporation 10-Year Revenue, Profit & Cash Flow History
Annual Financials
FY2025 - FY2016| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.9B(-74.0%) | $22.6B(+32.1%) | $17.1B(+19.2%) | $14.4B(-16.1%) | $17.1B(+25.8%) | $13.6B(+9.3%) | $12.4B(+9.9%) | $11.3B(+13.9%) | $9.9B(+2.8%) | $9.7B(-2.7%) |
| Net Income | $654.0M(-78.1%) | $3.0B(+50.1%) | $2.0B(+24.7%) | $1.6B(-19.8%) | $2.0B(-43.9%) | $3.6B(+248.3%) | $1.0B(-38.1%) | $1.6B(+14.5%) | $1.4B(+179.4%) | $515.0M(-64.2%) |
| Total Assets | $47.8B | $43.0B | $39.9B | $36.9B | $34.6B | $30.2B | $27.2B | $22.2B | $20.4B | $16.2B |
| Total Debt | $14.9B | $12.2B | $10.9B | $11.9B | $12.5B | $13.2B | $10.2B | $8.5B | $6.6B | $6.7B |
| Total Equity | $22.4B | $20.6B | $16.6B | $14.9B | $14.9B | $12.8B | $11.7B | $10.0B | $10.0B | $9.6B |
| Profit Margin | 11.2% | 13.3% | 11.7% | 11.1% | 11.7% | 26.1% | 8.2% | 14.5% | 14.5% | 5.3% |
| ROE | 2.9% | 14.5% | 12.0% | 10.8% | 13.4% | 27.7% | 8.7% | 16.5% | 14.4% | 5.4% |
| ROA | 1.4% | 7.0% | 5.0% | 4.3% | 5.8% | 11.8% | 3.8% | 7.4% | 7.0% | 3.2% |
Quarterly Financials
Last 8 quarters| Metric | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.9B | $16.2B | $10.7B | $5.2B | $14.7B | $9.8B | $4.8B | $13.2B |
| Net Income | $654.0M | $2.4B | $1.6B | $788.0M | $2.0B | $1.3B | $592.0M | $1.8B |
| Total Assets | $47.8B | $43.0B | $43.0B | $43.0B | $39.9B | $39.9B | $39.9B | $36.9B |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026
2 insiders sold shares worth $181.9M, despite revenue growth of +11.2% YoY. Divergence signal strength: 40/100.
Insider Trading
Source: SEC EDGAR Form 4 filings. Only purchase (P) and sale (S) transactions shown.
Stryker Corporation Dividend Safety Analysis & Growth History
Dividend Status
Dividend PayerThis company pays dividends. Historical dividend data shown below.
5-year dividend CAGR: +1.4%.
Annual Dividends
2016 - 2025| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend/Share | $1.56 | $1.75 | $1.93 | $2.13 | $2.35 | $2.58 | $2.83 | $3.05 | $3.24 | $2.52 |
| YoY Growth | +10.6% | +11.5% | +10.6% | +10.6% | +10.3% | +9.8% | +9.7% | +7.6% | +6.2% | -22.2% |
| Payments | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 |
| Increased | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No |
Learn more: Dividend investing guide | How to evaluate dividend safety
As of FY2025 · SEC 10-K · Updated Jun 30, 2026
Stryker Corporation Free Cash Flow & Dividend Coverage
Generates approximately $12M in free cash flow per day.
Cash Flow History
FY2016 - FY2025| Metric | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | $1.8B | $981.0M | $1.9B | $1.6B | $2.6B | $3.3B | $3.3B | $3.3B | $4.2B | $5.0B |
| CapEx | -$233.0M | -$270.0M | -$490.0M | -$598.0M | -$572.0M | -$525.0M | -$487.0M | -$525.0M | -$755.0M | -$761.0M |
| Free Cash Flow | $1.5B | $711.0M | $1.4B | $961.0M | $2.0B | $2.7B | $2.8B | $2.7B | $3.5B | $4.3B |
| FCF Margin | 16.0% | 7.1% | 12.6% | 7.7% | 15.0% | 16.0% | 19.4% | 16.0% | 15.4% | 73.0% |
Source: SEC EDGAR 10-K filings. FCF = Operating Cash Flow - Capital Expenditures. Free cash flow guide
As of FY2025 · SEC 10-K · Updated Jun 30, 2026
Stryker Corporation Risk Factors
Company-disclosed SEC risk factors
Risk factors are disclosed by the company in its SEC Form 10-K, Item 1A. Billiver does not classify or summarize company-specific legal, operational, financial, or market risks here.
Sector context: Health Care. This is not a Billiver risk assessment for SYK.
Source note: the SEC Form 10-K includes Item 1A, "Risk Factors." The full risk-factor text should be read from the company’s own SEC filing.
Stryker Corporation FAQ
What is Stryker Corporation's annual revenue?
Stryker Corporation (SYK) reported $22.6 billion in trailing twelve-month (TTM) revenue. This financial data is compiled from SEC EDGAR 10-K filings.
Is Stryker Corporation profitable?
Yes, Stryker Corporation is profitable with a 13.3% net profit margin and $3.0 billion in net income (TTM). All figures from SEC EDGAR 10-K filings.
Does Stryker Corporation pay dividends?
Yes, Stryker Corporation pays regular dividends. View the full dividend history and payout analysis on this page.
What is Stryker Corporation's financial health score?
Stryker Corporation has a financial health score of 61/100 (Grade: C), evaluating profitability, solvency, liquidity, and growth based on SEC EDGAR data.
How many years of Stryker Corporation financial data are available?
10 years of financial data are available for Stryker Corporation from FY2016 to FY2025. All figures are compiled from SEC EDGAR 10-K filings.